AI entity
All 1 tracked stories fall under one category: ai-research. MIT is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 7, the average consequence score sits above the same-window beat average of 6.4. Each story carries 2 original sources on average, compared with 2.2 for the broader beat in this window.
Last mentioned: Mar 20, 2026
Entity pulse
Coverage balance Positive coverage leads. Positive coverage exceeds negative coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: ai-research. MIT is the most frequent co-covered peer, appearing in 1 of the 1 tracked story. At 7, the average consequence score sits above the same-window beat average of 6.4. Each story carries 2 original sources on average, compared with 2.2 for the broader beat in this window. Multi-omics appears in 1 tracked AI story from March 10, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 38 AI stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Multi-omics. Shared-story counts are live from our verified record — not editorial picks.
MIT researchers have unveiled advanced predictive models designed to characterize the complex evolutionary trajectories of tumors. By leveraging machine learning to analyze multi-dimensional biological data, the team aims to forecast cancer progression and optimize personalized treatment interventions.
Multi-omics is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
